Skip to main content

Market Overview

Baird Still Isn't Buying Biogen


While reporting a significant EPS beat for Q2, Biogen Inc (NASDAQ: BIIB) also announced the departure of its CEO. Baird’s Brian P. Skorney maintained a Neutral rating on the company, with a $268 price target.

The stock appreciated following the announcement, since “investors have largely held Scangos accountable for the stock's underperformance over the last year,” Skorney mentioned, while adding, “[B]ut we're not so sure the departure is a signal of improving fundamentals.”

Q2 Earnings

The company reported its non-GAAP diluted EPS at $5.21, 10 percent above the estimate and the consensus, driven by higher than expected revenues, which also beat the estimate and the consensus. The beat was also aided by lower operating expenses.

Related Link: Biogen's Q2 Numbers, Outlook Exceed Street Expectations

Management significantly raised the EPS guidance, due to modestly higher revenue for the year, along with lower guidance for R&D and SG&A than previously guided.

MS Sales

“Biogen's MS franchise produced $2.23B in sales in the second quarter, up from $2.11B in Q1 and $2.06B in 1Q15,” Skorney stated.

MS sales modestly beat expectations, and while no inventory gains were specifically mentioned, the analyst believes that sales benefited from inventory builds during Q2.

Buyback Authorization

In addition, Skorney expressed regarding Biogen’s buyback authorization of $5 billion, which is almost the same amount the company raised in debt offering in the fall of 2015 and had been seen as a signal that the company would undertake acquisitions.

Did you like this article? Could it have been improved? Please email with the story link to let us know!

Latest Ratings for BIIB

Apr 2021Morgan StanleyMaintainsOverweight
Apr 2021WedbushMaintainsNeutral
Feb 2021Cantor FitzgeraldMaintainsNeutral

View More Analyst Ratings for BIIB
View the Latest Analyst Ratings


Related Articles (BIIB)

View Comments and Join the Discussion!

Posted-In: Baird Brian P. SkorneyAnalyst Color Reiteration Analyst Ratings

Latest Ratings

LAZRB of A SecuritiesInitiates Coverage On
TXRHStephens & Co.Maintains93.0
RUTHStephens & Co.Maintains30.0
FBIORoth CapitalMaintains5.0
CHUYStephens & Co.Downgrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at